{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T17:44:10Z","timestamp":1790963050395,"version":"4.1.0"},"reference-count":174,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"DBT","award":["BT\/PR7240\/MED\/30\/915\/2012"],"award-info":[{"award-number":["BT\/PR7240\/MED\/30\/915\/2012"]}]},{"name":"DST","award":["SB\/SO\/AS-126\/2012"],"award-info":[{"award-number":["SB\/SO\/AS-126\/2012"]}]},{"name":"FIST","award":["SR\/FST\/LSI-384\/2008"],"award-info":[{"award-number":["SR\/FST\/LSI-384\/2008"]}]},{"name":"UGC-SAP","award":["F.3-26\/2011"],"award-info":[{"award-number":["F.3-26\/2011"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Mutation Research\/Reviews in Mutation Research"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/j.mrrev.2017.03.001","type":"journal-article","created":{"date-parts":[[2017,3,18]],"date-time":"2017-03-18T12:15:25Z","timestamp":1489839325000},"page":"14-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":72,"special_numbering":"C","title":["Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions"],"prefix":"10.1016","volume":"773","author":[{"given":"Younis Mohammad","family":"Hazari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arif","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mudasir","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samirul","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huma","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Abul","family":"Qasim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed Nazir","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehtishamul","family":"Haq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Teckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid Majid","family":"Fazili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0005","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1172\/JCI112524","article-title":"Expression of the alpha-1-antitrypsin gene in mononuclear phagocytes of normal and alpha-1-antitrypsin-deficient individuals","volume":"77","author":"Mornex","year":"1986","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0010","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1172\/JCI113999","article-title":"Accumulation of PiZ alpha 1-antitrypsin causes liver damage in transgenic mice","volume":"83","author":"Carlson","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0015","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1172\/JCI116797","article-title":"Cell-specific expression of alpha 1-antitrypsin in human intestinal epithelium","volume":"92","author":"Molmenti","year":"1993","journal-title":"J. Clin. Invest."},{"issue":"13","key":"10.1016\/j.mrrev.2017.03.001_bib0020","doi-asserted-by":"crossref","first-page":"8250","DOI":"10.1074\/jbc.272.13.8250","article-title":"Biosynthesis of alpha1-proteinase inhibitor by human lung-derived epithelial cells","volume":"272","author":"Cichy","year":"1997","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0025","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1378\/chest.125.5.1952","article-title":"Z alpha1-antitrypsin polymerizes in the lung and acts as a neutrophil chemoattractant","volume":"125","author":"Mulgrew","year":"2004","journal-title":"Chest"},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0030","first-page":"068","article-title":"Plant protease inhibitors: a defence strategy in plants","volume":"2","author":"Habib","year":"2007","journal-title":"Biotechnol. Mol. Biol. Rev."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4137\/BMI.S1115","article-title":"Low serum alpha-1 antitrypsin (AAT) in family members of individuals with autism correlates with PiMZ genotype","volume":"4","author":"Russo","year":"2009","journal-title":"Biomark. Insights"},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0040","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0925-4439(94)90089-2","article-title":"The effect of the Z mutation on the ability of alpha 1-antitrypsin to prevent neutrophil mediated tissue damage","volume":"1227","author":"Llewellyn-Jones","year":"1994","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0045","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1056\/NEJM198309223091203","article-title":"Mutation of antitrypsin to antithrombin. alpha 1-antitrypsin Pittsburgh (358 Met leads to Arg): a fatal bleeding disorder","volume":"309","author":"Owen","year":"1983","journal-title":"N. Engl. J. Med."},{"issue":"Pt 12","key":"10.1016\/j.mrrev.2017.03.001_bib0050","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1107\/S1744309111040267","article-title":"Therapeutic target-site variability in alpha1-antitrypsin characterized at high resolution","volume":"67","author":"Patschull","year":"2011","journal-title":"Acta Crystallogr. Sect F Struct. Biol. Cryst. Commun."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0055","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7861\/clinmedicine.5-3-249","article-title":"Molecular mousetraps: alpha1-antitrypsin deficiency and the serpinopathies","volume":"5","author":"Lomas","year":"2005","journal-title":"Clin. Med. (Lond.)"},{"issue":"Pt 2","key":"10.1016\/j.mrrev.2017.03.001_bib0060","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1042\/BST0330321","article-title":"Molecular mousetraps and the serpinopathies","volume":"33","author":"Lomas","year":"2005","journal-title":"Biochem. Soc. Trans."},{"issue":"36","key":"10.1016\/j.mrrev.2017.03.001_bib0065","doi-asserted-by":"crossref","first-page":"33293","DOI":"10.1074\/jbc.R100016200","article-title":"The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution: mechanism of inhibition, novel functions, and a revised nomenclature","volume":"276","author":"Silverman","year":"2001","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0070","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1186\/gb-2006-7-5-216","article-title":"An overview of the serpin superfamily","volume":"7","author":"Law","year":"2006","journal-title":"Genome Biol."},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0075","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.1101\/gr.147800","article-title":"Phylogeny of the serpin superfamily: implications of patterns of amino acid conservation for structure and function","volume":"10","author":"Irving","year":"2000","journal-title":"Genome Res."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0080","first-page":"343","article-title":"Physical mapping of four serpin genes: alpha 1-antitrypsin, alpha 1-antichymotrypsin, corticosteroid-binding globulin, and protein C inhibitor, within a 280-kb region on chromosome I4q32.1","volume":"52","author":"Billingsley","year":"1993","journal-title":"Am. J. Hum. Genet."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0085","first-page":"868","article-title":"Chromosomal localization of the human alpha 1-antitrypsin gene (PI) to 14q31-32","volume":"37","author":"Schroeder","year":"1985","journal-title":"Am. J. Hum. Genet."},{"issue":"9","key":"10.1016\/j.mrrev.2017.03.001_bib0090","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/j.1460-2075.1987.tb02571.x","article-title":"The human alpha 1-antitrypsin gene is transcribed from two different promoters in macrophages and hepatocytes","volume":"6","author":"Perlino","year":"1987","journal-title":"EMBO J."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0095","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1590\/S1415-47572009005000107","article-title":"Alpha-1 antitrypsin gene polymorphism in chronic obstructive pulmonary disease (COPD)","volume":"33","author":"Denden","year":"2010","journal-title":"Genet. Mol. Biol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0100","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rmed.2016.06.005","article-title":"Novel variants of SERPIN1A gene: interplay between alpha1-antitrypsin deficiency and chronic obstructive pulmonary disease","volume":"117","author":"Bashir","year":"2016","journal-title":"Respir. Med."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0105","first-page":"660","article-title":"Genetic variation of alpha 1-antitrypsin","volume":"30","author":"Cox","year":"1978","journal-title":"Am. J. Hum. Genet."},{"issue":"11","key":"10.1016\/j.mrrev.2017.03.001_bib0110","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1089\/gtmb.2012.0152","article-title":"Alpha-1-antitrypsin deficiency in serbian adults with lung diseases","volume":"16","author":"Topic","year":"2012","journal-title":"Genet. Test. Mol. Biomarkers"},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0115","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/humu.1380020311","article-title":"Genetic diversity from a limited repertoire of mutations on different common allelic backgrounds: alpha 1-antitrypsin deficiency variant Pduarte","volume":"2","author":"Hildesheim","year":"1993","journal-title":"Hum. Mutat."},{"issue":"34","key":"10.1016\/j.mrrev.2017.03.001_bib0120","doi-asserted-by":"crossref","first-page":"15989","DOI":"10.1016\/S0021-9258(18)66664-5","article-title":"Identification of a second mutation in the protein-coding sequence of the Z type alpha 1-antitrypsin gene","volume":"261","author":"Nukiwa","year":"1986","journal-title":"J. Biol. Chem."},{"issue":"14","key":"10.1016\/j.mrrev.2017.03.001_bib0125","doi-asserted-by":"crossref","first-page":"9548","DOI":"10.1074\/jbc.274.14.9548","article-title":"A kinetic mechanism for the polymerization of alpha1-antitrypsin","volume":"274","author":"Dafforn","year":"1999","journal-title":"J. Biol. Chem."},{"issue":"6379","key":"10.1016\/j.mrrev.2017.03.001_bib0130","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1038\/357605a0","article-title":"The mechanism of Z alpha 1-antitrypsin accumulation in the liver","volume":"357","author":"Lomas","year":"1992","journal-title":"Nature"},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0135","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1056\/NEJM198603203141202","article-title":"Risk of cirrhosis and primary liver cancer in alpha 1-antitrypsin deficiency","volume":"314","author":"Eriksson","year":"1986","journal-title":"N. Engl. J. Med."},{"issue":"6 Pt 1","key":"10.1016\/j.mrrev.2017.03.001_bib0140","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1164\/ajrccm.152.6.8520784","article-title":"Alpha 1-antitrypsin-deficient variant siiyama (Ser53[TCC] to Phe53[TTC]) is prevalent in japan. status of alpha 1-antitrypsin deficiency in Japan","volume":"152","author":"Seyama","year":"1995","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0145","first-page":"233","article-title":"Molecular abnormality of PI S variant of human alpha1-antitrypsin","volume":"29","author":"Yoshida","year":"1977","journal-title":"Am. J. Hum. Genet."},{"issue":"8","key":"10.1016\/j.mrrev.2017.03.001_bib0150","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nsb0896-676","article-title":"Inhibitory conformation of the reactive loop of alpha 1-antitrypsin","volume":"3","author":"Elliott","year":"1996","journal-title":"Nat. Struct. Biol."},{"issue":"6 Pt 1","key":"10.1016\/j.mrrev.2017.03.001_bib0155","doi-asserted-by":"crossref","first-page":"1718","DOI":"10.1164\/ajrccm.154.6.8970361","article-title":"Clinical features of individuals with PI*SZ phenotype of alpha 1-antitrypsin deficiency: alpha 1-antitrypsin deficiency registry study group","volume":"154","author":"Turino","year":"1996","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"7","key":"10.1016\/j.mrrev.2017.03.001_bib0160","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1172\/JCI4874","article-title":"Heteropolymerization of S, I, and Z alpha1-antitrypsin and liver cirrhosis","volume":"103","author":"Mahadeva","year":"1999","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0165","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1164\/ajrccm\/140.6.1662","article-title":"Characterization of the intracellular mechanism causing the alpha-1-antitrypsin Nullgranite falls deficiency state","volume":"140","author":"Holmes","year":"1989","journal-title":"Am. Rev. Respir. Dis."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0170","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1172\/JCI113994","article-title":"Alpha 1-antitrypsin deficiency caused by the alpha 1-antitrypsin nullmattawa gene: an insertion mutation rendering the alpha 1-antitrypsin gene incapable of producing alpha 1-antitrypsin","volume":"83","author":"Curiel","year":"1989","journal-title":"J. Clin. Invest."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0175","first-page":"77","article-title":"Emphysema associated with complete absence of alpha 1- antitrypsin in serum and the homozygous inheritance [corrected] of a stop codon in an alpha 1-antitrypsin-coding exon","volume":"42","author":"Satoh","year":"1988","journal-title":"Am. J. Hum. Genet."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0180","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/j.rmed.2008.01.009","article-title":"Alpha-1 antitrypsin Null mutations and severity of emphysema","volume":"102","author":"Fregonese","year":"2008","journal-title":"Respir. Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0185","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1111\/j.1445-5994.1994.tb02170.x","article-title":"Absence of alpha-1-antitrypsin (Pi Null Bellingham) and the early onset of emphysema","volume":"24","author":"Cook","year":"1994","journal-title":"Aust. N. Z. J. Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0190","first-page":"403","article-title":"Alpha 1-antitrypsin null(isola di procida): an alpha 1-antitrypsin deficiency allele caused by deletion of all alpha 1-antitrypsin coding exons","volume":"47","author":"Takahashi","year":"1990","journal-title":"Am. J. Hum. Genet."},{"issue":"15","key":"10.1016\/j.mrrev.2017.03.001_bib0195","doi-asserted-by":"crossref","first-page":"7330","DOI":"10.1016\/S0021-9258(18)68646-6","article-title":"A frameshift mutation results in a truncated alpha 1-antitrypsin that is retained within the rough endoplasmic reticulum","volume":"263","author":"Sifers","year":"1988","journal-title":"J. Biol. Chem."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0200","doi-asserted-by":"crossref","first-page":"228","DOI":"10.3109\/03009730903243472","article-title":"Alpha-1-antitrypsin phenotypes in adult liver disease patients","volume":"114","author":"Topic","year":"2009","journal-title":"Ups. J. Med. Sci."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0205","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1007\/s00011-004-1335-4","article-title":"The influence of vitamin C on systemic markers of endothelial and inflammatory cell activation in smokers and non-smokers","volume":"54","author":"Scott","year":"2005","journal-title":"Inflamm. Res."},{"issue":"23","key":"10.1016\/j.mrrev.2017.03.001_bib0210","doi-asserted-by":"crossref","first-page":"13938","DOI":"10.1016\/S0021-9258(18)80090-4","article-title":"Molecular basis of the liver and lung disease associated with the alpha 1-antitrypsin deficiency allele Mmalton","volume":"264","author":"Curiel","year":"1989","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0215","first-page":"30","article-title":"Molecular characterization of the new defective P(brescia) alpha1-antitrypsin allele","author":"Medicina","year":"2009","journal-title":"Hum. Mut."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0220","doi-asserted-by":"crossref","first-page":"e38405","DOI":"10.1371\/journal.pone.0038405","article-title":"Three new alpha1-antitrypsin deficiency variants help to define a C-terminal region regulating conformational change and polymerization","volume":"7","author":"Fra","year":"2012","journal-title":"PLoS One"},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0225","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1165\/ajrcmb\/1.6.471","article-title":"Characterization of the sequence of the normal alpha-1-antitrypsin M3 allele and function of the M3 protein","volume":"1","author":"Curiel","year":"1989","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0230","first-page":"322","article-title":"Characterization of the gene and protein of the common alpha 1-antitrypsin normal M2 allele","volume":"43","author":"Nukiwa","year":"1988","journal-title":"Am. J. Hum. Genet."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0235","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/BF00282302","article-title":"PI. (alpha 1-antitrypsin) subtypes: frequency of PI*M4 in several populations","volume":"62","author":"Klasen","year":"1982","journal-title":"Hum. Genet."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0240","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/sj.ejhg.5200304","article-title":"Molecular characterisation of the defective alpha 1-antitrypsin alleles PI mwurzburg (Pro369Ser): mheerlen (Pro369Leu), and Q0lisbon (Thr68Ile)","volume":"7","author":"Poller","year":"1999","journal-title":"Eur. J. Hum. Genet."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0245","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s13023-015-0350-6","article-title":"Clinical heterogeneity and potential high pathogenicity of the Mmalton alpha 1 antitrypsin allele at the homozygous, compound heterozygous and heterozygous states","volume":"10","author":"Joly","year":"2015","journal-title":"Orphanet J. Rare Dis."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0250","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1136\/jmg.2004.023903","article-title":"Prevalence and phenotype of subjects carrying rare variants in the Italian registry for alpha1-antitrypsin deficiency","volume":"42","author":"Ferrarotti","year":"2005","journal-title":"J. Med. Genet."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0255","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1344-6223(01)00040-2","article-title":"Molecular characterization of four alpha-1-antitrypsin variant alleles found in a Japanese population: a mutation hot spot at the codon for amino acid 362","volume":"3","author":"Yuasa","year":"2001","journal-title":"Leg. Med. (Tokyo)"},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0260","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13023-014-0172-y","article-title":"Identification and characterisation of eight novel SERPINA1 Null mutations","volume":"9","author":"Ferrarotti","year":"2014","journal-title":"Orphanet J. Rare Dis."},{"issue":"Suppl. C","key":"10.1016\/j.mrrev.2017.03.001_bib0265","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1053\/rmed.2000.0851","article-title":"Molecular mechanisms of alpha1-antitrypsin null alleles","volume":"94","author":"Lee","year":"2000","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0270","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1097\/01.pas.0000155023.74859.d6","article-title":"Identification of a novel alpha1-antitrypsin null variant (Q0Cairo)","volume":"14","author":"Zorzetto","year":"2005","journal-title":"Diagn. Mol. Pathol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0275","first-page":"294","article-title":"Identification of compound heterozygous mutation in a Korean patient with alpha 1-antitrypsin deficiency","volume":"31","author":"Ko","year":"2011","journal-title":"Korean J. Lab. Med."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0280","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.arbr.2014.11.019","article-title":"Description of alpha-1-antitrypsin deficiency associated with PI*Q0ourem allele in La Palma Island (Spain) and a genotyping assay for its detection","volume":"51","author":"Hernandez Perez","year":"2015","journal-title":"Arch. Bronconeumol."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0285","doi-asserted-by":"crossref","first-page":"1878","DOI":"10.1172\/JCI114919","article-title":"A null deficiency allele of alpha 1-antitrypsin: QOludwigshafen, with altered tertiary structure","volume":"86","author":"Frazier","year":"1990","journal-title":"J. Clin. Invest."},{"issue":"18","key":"10.1016\/j.mrrev.2017.03.001_bib0290","doi-asserted-by":"crossref","first-page":"10477","DOI":"10.1016\/S0021-9258(18)81646-5","article-title":"Serum alpha 1-antitrypsin deficiency associated with the common S-type (Glu264\u2014Val) mutation results from intracellular degradation of alpha 1-antitrypsin prior to secretion","volume":"264","author":"Curiel","year":"1989","journal-title":"J. Biol. Chem."},{"issue":"21","key":"10.1016\/j.mrrev.2017.03.001_bib0295","doi-asserted-by":"crossref","first-page":"15333","DOI":"10.1016\/S0021-9258(18)82258-X","article-title":"Alpha 1-antitrypsin siiyama (Ser53\u2013\u2009> Phe). further evidence for intracellular loop-sheet polymerization","volume":"268","author":"Lomas","year":"1993","journal-title":"J. Biol. Chem."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0300","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/0006-291X(90)90493-7","article-title":"Alpha 1-antitrypsin Wbethesda: molecular basis of an unusual alpha 1-antitrypsin deficiency variant","volume":"170","author":"Holmes","year":"1990","journal-title":"Biochem. Biophys. Res. Commun."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0305","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/0167-4838(86)90183-4","article-title":"alpha 1-antitrypsin Christchurch, 363 Glu\u2014Lys: mutation at the P'5 position does not affect inhibitory activity","volume":"873","author":"Brennan","year":"1986","journal-title":"Biochim. Biophys. Acta"},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0310","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1172\/JCI113214","article-title":"Z-type alpha 1-antitrypsin is less competent than M1-type alpha 1-antitrypsin as an inhibitor of neutrophil elastase","volume":"80","author":"Ogushi","year":"1987","journal-title":"J. Clin. Invest."},{"issue":"Suppl. 1","key":"10.1016\/j.mrrev.2017.03.001_bib0315","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3109\/15412555.2013.771956","article-title":"The electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiency. 1963","volume":"10","author":"Laurell","year":"2013","journal-title":"Copd"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0320","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1183\/09031936.99.13224799","article-title":"Decline in FEV1 related to smoking status in individuals with severe alpha1-antitrypsin deficiency (PiZZ)","volume":"13","author":"Piitulainen","year":"1999","journal-title":"Eur. Respir. J."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0325","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1006\/jmbi.1999.3375","article-title":"Conformational changes in serpins: I: the native and cleaved conformations of alpha(1)-antitrypsin","volume":"295","author":"Whisstock","year":"2000","journal-title":"J. Mol. Biol."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0330","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1378\/chest.122.5.1818","article-title":"Worldwide racial and ethnic distribution of alpha1-antitrypsin deficiency: summary of an analysis of published genetic epidemiologic surveys","volume":"122","author":"de Serres","year":"2002","journal-title":"Chest"},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0335","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1016\/j.humpath.2004.08.013","article-title":"The bronchopulmonary pathology of alpha-1 antitrypsin (AAT) deficiency: findings of the Death Review Committee of the national registry for individuals with severe deficiency of alpha-1 Antitrypsin","volume":"35","author":"Tomashefski","year":"2004","journal-title":"Hum. Pathol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0340","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1111\/j.1468-3083.2005.01194.x","article-title":"Alpha1-antitrypsin deficiency-associated panniculitis: case report and review of treatment options","volume":"19","author":"Ortiz","year":"2005","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"issue":"8","key":"10.1016\/j.mrrev.2017.03.001_bib0345","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.rmed.2011.02.002","article-title":"The discovery of alpha1-antitrypsin and its role in health and disease","volume":"105","author":"Janciauskiene","year":"2011","journal-title":"Respir. Med."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0350","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jvs.2010.02.291","article-title":"Successful endovascular treatment of multiple mesenteric arterial aneurysms associated with alpha-1-antitrypsin deficiency","volume":"52","author":"Gordon","year":"2010","journal-title":"J. Vasc. Surg."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0355","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1038\/sj.jhh.1000935","article-title":"Alpha-1-antitrypsin phenotypes in patients with renal arterial fibromuscular dysplasia","volume":"14","author":"Bofinger","year":"2000","journal-title":"J. Hum. Hypertens."},{"issue":"9","key":"10.1016\/j.mrrev.2017.03.001_bib0360","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1007\/BF02208669","article-title":"Alpha 1-antitrypsin deficiency and chronic pancreatitis","volume":"40","author":"Rabassa","year":"1995","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0365","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7434","article-title":"Alpha-1 antitrypsin deficiency PI*Z and PI*S gene frequency distribution using on maps of the world by an inverse distance weighting (IDW) multivariate interpolation method","volume":"12","author":"Blanco","year":"2012","journal-title":"Hepat. Mon."},{"issue":"23","key":"10.1016\/j.mrrev.2017.03.001_bib0370","doi-asserted-by":"crossref","first-page":"12617","DOI":"10.1128\/JVI.77.23.12617-12629.2003","article-title":"Endoplasmic reticulum stress is a determinant of retrovirus-induced spongiform neurodegeneration","volume":"77","author":"Dimcheff","year":"2003","journal-title":"J. Virol."},{"issue":"10","key":"10.1016\/j.mrrev.2017.03.001_bib0375","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/thx.2004.022541","article-title":"Chronic obstructive pulmonary disease in alpha1-antitrypsin PI MZ heterozygotes: a meta-analysis","volume":"59","author":"Hersh","year":"2004","journal-title":"Thorax"},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0380","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1183\/09031936.06.00062305","article-title":"Estimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countries","volume":"27","author":"Blanco","year":"2006","journal-title":"Eur. Respir. J."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0385","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1136\/thorax.2003.006494","article-title":"Alpha1-antitrypsin deficiency. 1: epidemiology of alpha1-antitrypsin deficiency","volume":"59","author":"Luisetti","year":"2004","journal-title":"Thorax"},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0390","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1164\/rccm.201108-1428CI","article-title":"A review of alpha1-antitrypsin deficiency","volume":"185","author":"Stoller","year":"2012","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0395","doi-asserted-by":"crossref","DOI":"10.5812\/hepatmon.7042","article-title":"Alpha-1-antitrypsin in pathogenesis of hepatocellular carcinoma","volume":"12","author":"Topic","year":"2012","journal-title":"Hepat. Mon."},{"issue":"11","key":"10.1016\/j.mrrev.2017.03.001_bib0400","doi-asserted-by":"crossref","first-page":"E207","DOI":"10.1038\/35041139","article-title":"Conformational disease","volume":"2","author":"Kopito","year":"2000","journal-title":"Nat. Cell Biol."},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0405","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1042\/CS20080484","article-title":"alpha1-antitrypsin deficiency: chronic obstructive pulmonary disease and the serpinopathies","volume":"116","author":"Ekeowa","year":"2009","journal-title":"Clin. Sci. (Lond.)"},{"issue":"10","key":"10.1016\/j.mrrev.2017.03.001_bib0410","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1164\/rccm.200511-1797PP","article-title":"The selective advantage of alpha1-antitrypsin deficiency","volume":"173","author":"Lomas","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0415","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1378\/chest.89.3.370","article-title":"Alpha 1-antitrypsin pi-types in 965 COPD patients","volume":"89","author":"Lieberman","year":"1986","journal-title":"Chest"},{"issue":"19","key":"10.1016\/j.mrrev.2017.03.001_bib0420","doi-asserted-by":"crossref","first-page":"5109","DOI":"10.1093\/hmg\/ddu235","article-title":"A C. elegans model of human alpha1-antitrypsin deficiency links components of the RNAi pathway to misfolded protein turnover","volume":"23","author":"Long","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"19","key":"10.1016\/j.mrrev.2017.03.001_bib0425","doi-asserted-by":"crossref","first-page":"5123","DOI":"10.1093\/hmg\/ddu236","article-title":"A genome-wide RNAi screen identifies potential drug targets in a C: elegans model of alpha1-antitrypsin deficiency","volume":"23","author":"O'Reilly","year":"2014","journal-title":"Hum. Mol. Genet."},{"issue":"1\u20132","key":"10.1016\/j.mrrev.2017.03.001_bib0430","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/pr.2013.190","article-title":"Targeting intracellular degradation pathways for treatment of liver disease caused by alpha1-antitrypsin deficiency","volume":"75","author":"Wang","year":"2014","journal-title":"Pediatr. Res."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0435","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10545-007-0748-y","article-title":"Alpha-1 antitrypsin deficiency: a conformational disease associated with lung and liver manifestations","volume":"31","author":"Greene","year":"2008","journal-title":"J. Inherit. Metab. Dis."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0440","first-page":"14","article-title":"Emerging tale of UPR and cancer: an essentiality for malignancy","volume":"14","author":"Hazari","year":"2016","journal-title":"Tumour Biol."},{"issue":"47","key":"10.1016\/j.mrrev.2017.03.001_bib0445","doi-asserted-by":"crossref","first-page":"39002","DOI":"10.1074\/jbc.M508652200","article-title":"Accumulation of mutant alpha1-antitrypsin Z in the endoplasmic reticulum activates caspases-4 and \u221212: NFkappaB, and BAP31 but not the unfolded protein response","volume":"280","author":"Hidvegi","year":"2005","journal-title":"J. Biol. Chem."},{"issue":"24","key":"10.1016\/j.mrrev.2017.03.001_bib0450","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJM197606102942404","article-title":"Liver disease in alpha1-antitrypsin deficiency detected by screening of 200,000 infants","volume":"294","author":"Sveger","year":"1976","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0455","first-page":"160","article-title":"Heterozygous alpha-I antitrypsin deficiency as a co-factor in the development of chronic liver disease: a review","volume":"65","author":"Kok","year":"2007","journal-title":"Neth. J. Med."},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0460","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1093\/ajcn\/41.1.66","article-title":"Vitamin E deficiency in adults with chronic liver disease","volume":"41","author":"Sokol","year":"1985","journal-title":"Am. J. Clin. Nutr."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0465","first-page":"113","article-title":"Alpha-1-antitrypsin deficiency: an overview of recent advances","volume":"2","author":"El Hazmi","year":"1996","journal-title":"Saudi J. Gastroenterol."},{"issue":"Suppl. 6","key":"10.1016\/j.mrrev.2017.03.001_bib0470","doi-asserted-by":"crossref","first-page":"251S","DOI":"10.1378\/chest.110.6_Supplement.251S","article-title":"Pathogenesis and pathology of liver disease associated with alpha 1-antitrypsin deficiency","volume":"110","author":"Massi","year":"1996","journal-title":"Chest"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0475","first-page":"151","article-title":"Alpha(1)-antitrypsin deficiency: current perspective on research, diagnosis, and management","volume":"1","author":"Stolk","year":"2006","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0480","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S1542-3565(05)00082-0","article-title":"Factors associated with advanced liver disease in adults with alpha1-antitrypsin deficiency","volume":"3","author":"Bowlus","year":"2005","journal-title":"Clin. Gastroenterol. Hepatol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0485","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/hep.21822","article-title":"Alpha-1-antitrypsin mutant Z protein content in individual hepatocytes correlates with cell death in a mouse model","volume":"46","author":"Lindblad","year":"2007","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0490","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1161\/01.CIR.43.2.227","article-title":"Pathophysiology of the pulmonary circulation in emphysema associated with alpha antitrypsin deficiency","volume":"43","author":"Stein","year":"1971","journal-title":"Circulation"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0495","first-page":"253","article-title":"A matched-pair study of the leukocyte elastase-like activity in normal persons and in emphysematous patients with and without alpha 1-antitrypsin deficiency","volume":"121","author":"Kramps","year":"1980","journal-title":"Am. Rev. Respir. Dis."},{"issue":"12","key":"10.1016\/j.mrrev.2017.03.001_bib0500","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1074\/jbc.M607976200","article-title":"Alpha1-antitrypsin: old dog, new tricks: alpha1-antitrypsin exerts in vitro anti-inflammatory activity in human monocytes by elevating cAMP","volume":"282","author":"Janciauskiene","year":"2007","journal-title":"J. Biol. Chem."},{"issue":"10 Pt 1","key":"10.1016\/j.mrrev.2017.03.001_bib0505","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.1164\/ajrccm.164.10.2106036","article-title":"Longitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with decline","volume":"164","author":"Dowson","year":"2001","journal-title":"Am. J. Respir. Crit. Care Med."},{"issue":"9478","key":"10.1016\/j.mrrev.2017.03.001_bib0510","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1016\/S0140-6736(05)66781-5","article-title":"Alpha1-antitrypsin deficiency","volume":"365","author":"Stoller","year":"2005","journal-title":"Lancet"},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0515","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1136\/thx.2003.006510","article-title":"\u03b1(1)-Antitrypsin deficiency \u2022 3: clinical manifestations and natural history","volume":"59","author":"Needham","year":"2004","journal-title":"Thorax"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0520","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S0022-3476(05)82882-3","article-title":"Long-term follow-up of a cohort of children with alpha-1-antitrypsin deficiency","volume":"116","author":"Wall","year":"1990","journal-title":"J. Pediatr."},{"issue":"8421","key":"10.1016\/j.mrrev.2017.03.001_bib0525","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0140-6736(85)91916-6","article-title":"Smoking: lung function, and alpha 1-antitrypsin deficiency","volume":"1","author":"Janus","year":"1985","journal-title":"Lancet"},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0530","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S0002-9440(10)62261-4","article-title":"Polymers of Z alpha1-antitrypsin co-localize with neutrophils in emphysematous alveoli and are chemotactic in vivo","volume":"166","author":"Mahadeva","year":"2005","journal-title":"Am. J. Pathol."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0535","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1513\/pats.200904-016DS","article-title":"Burden and pathogenesis of chronic obstructive pulmonary disease","volume":"6","author":"Stockley","year":"2009","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0540","doi-asserted-by":"crossref","first-page":"L757","DOI":"10.1152\/ajplung.00271.2001","article-title":"Cell-specific involvement of HNF-1beta in alpha(1)-antitrypsin gene expression in human respiratory epithelial cells","volume":"282","author":"Hu","year":"2002","journal-title":"Am. J. Physiol. Lung Cell. Mol. Physiol."},{"issue":"7","key":"10.1016\/j.mrrev.2017.03.001_bib0545","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1136\/thx.49.7.695","article-title":"Survival of patients with severe alpha 1-antitrypsin deficiency with special reference to non-index cases","volume":"49","author":"Seersholm","year":"1994","journal-title":"Thorax"},{"issue":"17","key":"10.1016\/j.mrrev.2017.03.001_bib0550","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1056\/NEJM198704233161704","article-title":"Replacement therapy for alpha 1-antitrypsin deficiency associated with emphysema","volume":"316","author":"Wewers","year":"1987","journal-title":"N. Engl. J. Med."},{"issue":"9","key":"10.1016\/j.mrrev.2017.03.001_bib0555","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1016\/S0021-9258(19)85615-6","article-title":"Kinetics of association of serine proteinases with native and oxidized alpha-1-proteinase inhibitor and alpha-1-antichymotrypsin","volume":"255","author":"Beatty","year":"1980","journal-title":"J. Biol. Chem."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0560","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1165\/ajrcmb.18.5.3065","article-title":"Lung polymers in Z alpha1-antitrypsin deficiency-related emphysema","volume":"18","author":"Elliott","year":"1998","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"11","key":"10.1016\/j.mrrev.2017.03.001_bib0565","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1172\/JCI0216782","article-title":"Alpha1-antitrypsin polymerization and the serpinopathies: pathobiology and prospects for therapy","volume":"110","author":"Lomas","year":"2002","journal-title":"J. Clin. Invest."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0570","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1172\/JCI115391","article-title":"Neutrophil accumulation in the lung in alpha 1-antitrypsin deficiency: Spontaneous release of leukotriene B4 by alveolar macrophages","volume":"88","author":"Hubbard","year":"1991","journal-title":"J. Clin. Invest."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0575","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1165\/ajrcmb.26.6.4739","article-title":"Polymers of alpha(1)-antitrypsin are chemotactic for human neutrophils: a new paradigm for the pathogenesis of emphysema","volume":"26","author":"Parmar","year":"2002","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0580","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1084\/jem.167.5.1608","article-title":"The inhibitory complex of human alpha 1-proteinase inhibitor and human leukocyte elastase is a neutrophil chemoattractant","volume":"167","author":"Banda","year":"1988","journal-title":"J. Exp. Med."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0585","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1172\/JCI109926","article-title":"Chemotactic activity of elastin-derived peptides","volume":"66","author":"Senior","year":"1980","journal-title":"J. Clin. Invest."},{"issue":"9","key":"10.1016\/j.mrrev.2017.03.001_bib0590","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1136\/adc.66.9.1057","article-title":"Panniculitis: a report of four cases and literature review","volume":"66","author":"Randle","year":"1991","journal-title":"Arch. Dis. Child."},{"issue":"10","key":"10.1016\/j.mrrev.2017.03.001_bib0595","first-page":"877","article-title":"Weber-Christian syndrome associated with an alpha-1 antitrypsin deficiency: Familial investigation","volume":"123","author":"Warter","year":"1972","journal-title":"Ann. Med. Interne (Paris)"},{"issue":"1","key":"10.1016\/j.mrrev.2017.03.001_bib0600","doi-asserted-by":"crossref","first-page":"21245","DOI":"10.5070\/D3201021245","article-title":"Alpha-1-antitrypsin deficiency-associated panniculitis: a case report","volume":"20","author":"Laureano","year":"2014","journal-title":"Dermatol. Online J."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0605","first-page":"155","article-title":"On the evidence that augmentation therapy helps asthma: are storks really responsible for new babies?","volume":"69","author":"Stoller","year":"2008","journal-title":"Monaldi Arch. Chest Dis."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0610","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1159\/000202982","article-title":"New findings in PiZZ \u03b1(1)-antitrypsin deficiency-related panniculitis: demonstration of skin polymers and high dosing requirements of intravenous augmentation therapy","volume":"218","author":"Gross","year":"2009","journal-title":"Dermatology (Basel, Switzerland)"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0615","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/1750-1172-6-14","article-title":"Efficacy of alpha1-antitrypsin augmentation therapy in conditions other than pulmonary emphysema","volume":"6","author":"Blanco","year":"2011","journal-title":"Orphanet J. Rare Dis."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0620","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1007\/978-1-4757-9182-2_54","article-title":"Alpha-1-proteinase inhibitor and pulmonary haemorrhage in systemic vasculitis","volume":"336","author":"O'Donoghue","year":"1993","journal-title":"Adv. Exp. Med. Biol."},{"issue":"6","key":"10.1016\/j.mrrev.2017.03.001_bib0625","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1038\/ki.1993.186","article-title":"Alpha 1-antitrypsin genetic polymorphism in ANCA-positive systemic vasculitis","volume":"43","author":"Esnault","year":"1993","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0630","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1038\/ki.1995.360","article-title":"The PiZ gene of alpha 1-antitrypsin as a determinant of outcome in PR3-ANCA-positive vasculitis","volume":"48","author":"Segelmark","year":"1995","journal-title":"Kidney Int."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0635","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1093\/oxfordjournals.ndt.a027308","article-title":"C-antineutrophil cytoplasmic antibody positivity in vasculitis patients is associated with the Z allele of alpha-1-antitrypsin: and P-antineutrophil cytoplasmic antibody positivity with the S allele","volume":"11","author":"Griffith","year":"1996","journal-title":"Nephrol. Dial. Transplant."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0640","first-page":"206","article-title":"Alpha-1-antitrypsin phenotyping in ANCA-associated diseases: one of several arguments for protease\/antiprotease imbalance in systemic vasculitis","volume":"14","author":"Esnault","year":"1997","journal-title":"Exp. Clin. Immunogenet."},{"issue":"3","key":"10.1016\/j.mrrev.2017.03.001_bib0645","doi-asserted-by":"crossref","first-page":"291","DOI":"10.2174\/1568010023344607","article-title":"Oxidative stress and gene transcription in asthma and chronic obstructive pulmonary disease: antioxidant therapeutic targets","volume":"1","author":"Rahman","year":"2002","journal-title":"Curr. Drug Targets Inflamm. Allergy"},{"issue":"4424","key":"10.1016\/j.mrrev.2017.03.001_bib0650","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1126\/science.316187","article-title":"Cigarette smoke inhalation decreases alpha 1-antitrypsin activity in rat lung","volume":"206","author":"Janoff","year":"1979","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0655","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1749-6632.1993.tb39148.x","article-title":"Oxidants in cigarette smoke radicals, hydrogen peroxide, peroxynitrate, and peroxynitrite","volume":"686","author":"Pryor","year":"1993","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0660","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1513\/pats.200708-126ET","article-title":"Pathogenesis of emphysema: from the bench to the bedside","volume":"5","author":"Sharafkhaneh","year":"2008","journal-title":"Proc. Am. Thorac. Soc."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0665","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1165\/rcmb.2009-0221OC","article-title":"Cigarette smoke induces nucleic-acid oxidation in lung fibroblasts","volume":"43","author":"Deslee","year":"2010","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0670","first-page":"81","article-title":"Potential role of stem cells in management of COPD","volume":"5","author":"Hackett","year":"2010","journal-title":"Int. J. Chron. Obstruct. Pulmon. Dis."},{"issue":"28","key":"10.1016\/j.mrrev.2017.03.001_bib0675","doi-asserted-by":"crossref","first-page":"25486","DOI":"10.1074\/jbc.M203089200","article-title":"The reactivity and oxidation pathway of cysteine 232 in recombinant human alpha 1-antitrypsin","volume":"277","author":"Griffiths","year":"2002","journal-title":"J. Biol. Chem."},{"issue":"35","key":"10.1016\/j.mrrev.2017.03.001_bib0680","doi-asserted-by":"crossref","first-page":"27258","DOI":"10.1016\/S0021-9258(19)61505-X","article-title":"Oxidation of either methionine 351 or methionine 358 in alpha 1-antitrypsin causes loss of anti-neutrophil elastase activity","volume":"275","author":"Taggart","year":"2000","journal-title":"J. Biol. Chem."},{"issue":"2","key":"10.1016\/j.mrrev.2017.03.001_bib0685","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1165\/rcmb.2010-0328OC","article-title":"Oxidation of Z alpha1-antitrypsin by cigarette smoke induces polymerization: a novel mechanism of early-onset emphysema","volume":"45","author":"Alam","year":"2011","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0690","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.2353\/ajpath.2006.060058","article-title":"alpha-1 antitrypsin inhibits caspase-3 activity: preventing lung endothelial cell apoptosis","volume":"169","author":"Petrache","year":"2006","journal-title":"Am. J. Pathol."},{"issue":"Suppl. C","key":"10.1016\/j.mrrev.2017.03.001_bib0695","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1053\/rmed.2000.0854","article-title":"Alpha1-antitrypsin deficiency: incidence and detection program","volume":"94","author":"Campbell","year":"2000","journal-title":"Respir. Med."},{"issue":"8","key":"10.1016\/j.mrrev.2017.03.001_bib0700","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1111\/j.1572-0241.2008.01955.x","article-title":"Liver disease in alpha 1-antitrypsin deficiency: a review","volume":"103","author":"Fairbanks","year":"2008","journal-title":"Am. J. Gastroenterol."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0705","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1081\/JDI-120022550","article-title":"Serum alpha1-antitrypsin but not complement C3 and C4 predicts chronic inflammation in hemodialysis patients","volume":"25","author":"Borawski","year":"2003","journal-title":"Ren. Fail."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0710","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.jaci.2007.12.1183","article-title":"Issues in the diagnosis of alpha 1-antitrypsin deficiency","volume":"121","author":"Rachelefsky","year":"2008","journal-title":"J. Allergy Clin. Immunol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0715","doi-asserted-by":"crossref","first-page":"459823","DOI":"10.1155\/2014\/459823","article-title":"Capitalizing on the autophagic response for treatment of liver disease caused by alpha-1-antitrypsin deficiency and other genetic diseases","volume":"2014","author":"Chu","year":"2014","journal-title":"BioMed Res. Int."},{"issue":"4","key":"10.1016\/j.mrrev.2017.03.001_bib0720","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1242\/dmm.014092","article-title":"Mysteries of alpha1-antitrypsin deficiency: emerging therapeutic strategies for a challenging disease","volume":"7","author":"Ghouse","year":"2014","journal-title":"Dis. Model Mech."},{"issue":"5","key":"10.1016\/j.mrrev.2017.03.001_bib0725","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1172\/JCI110360","article-title":"Replacement therapy of alpha 1-antitrypsin deficiency: reversal of protease-antiprotease imbalance within the alveolar structures of PiZ subjects","volume":"68","author":"Gadek","year":"1981","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0730","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S0140-6736(15)60860-1","article-title":"Intravenous augmentation treatment and lung density in severe alpha1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trial","volume":"386","author":"Chapman","year":"2015","journal-title":"Lancet"},{"issue":"Suppl","key":"10.1016\/j.mrrev.2017.03.001_bib0735","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1007\/BF02718179","article-title":"Strategies for aerosol therapy of alpha 1-antitrypsin deficiency by the aerosol route","volume":"168","author":"Hubbard","year":"1990","journal-title":"Lung"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0740","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s00726-005-0324-4","article-title":"Recombinant human alpha-1 proteinase inhibitor: towards therapeutic use","volume":"30","author":"Karnaukhova","year":"2006","journal-title":"Amino Acids"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0745","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1164\/rccm.200508-1330OC","article-title":"Cystic fibrosis transmembrane conductance regulator function is suppressed in cigarette smokers","volume":"173","author":"Cantin","year":"2006","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0750","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/BF02521734","article-title":"Expression of human alpha 1 antitrypsin in transgenic sheep","volume":"9","author":"Carver","year":"1992","journal-title":"Cytotechnology"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0755","first-page":"1263","article-title":"Transgenic livestock as bioreactors: stable expression of human alpha-1-antitrypsin by a flock of sheep","volume":"11","author":"Carver","year":"1993","journal-title":"Biotechnology (Nature Publishing Company)"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0760","first-page":"830","article-title":"High level expression of active human alpha-1-antitrypsin in the milk of transgenic sheep","volume":"9","author":"Wright","year":"1991","journal-title":"Biotechnology (Nature Publishing Company)"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0765","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1056\/NEJM200505123521923","article-title":"Antibody response to aerosolized transgenic human alpha1-antitrypsin","volume":"352","author":"Spencer","year":"2005","journal-title":"New Engl. J. Med."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0770","first-page":"193","article-title":"Safety and efficacy of alpha-1-antitrypsin augmentation therapy in the treatment of patients with alpha-1-antitrypsin deficiency","volume":"3","author":"Petrache","year":"2009","journal-title":"Biologics"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0775","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nsb0595-363","article-title":"The Z type variation of human alpha 1-antitrypsin causes a protein folding defect","volume":"2","author":"Yu","year":"1995","journal-title":"Nat. Struct. Biol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0780","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.lfs.2016.01.002","article-title":"Natural osmolytes alleviate GRP78 and ATF-4 levels: corroboration for potential modulators of unfolded protein response","volume":"146","author":"Hazari","year":"2016","journal-title":"Life Sci."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0785","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1073\/pnas.97.4.1796","article-title":"Chemical chaperones mediate increased secretion of mutant alpha 1-antitrypsin (alpha 1-AT) Z: a potential pharmacological strategy for prevention of liver injury and emphysema in alpha 1-AT deficiency","volume":"97","author":"Burrows","year":"2000","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0790","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1165\/ajrcmb.24.6.4407","article-title":"Prevention of polymerization of M and Z alpha1-Antitrypsin (alpha1-AT) with trimethylamine N-oxide. Implications for the treatment of alpha1-at deficiency","volume":"24","author":"Devlin","year":"2001","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0795","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1089\/hum.1998.9.18-2709","article-title":"High doses of a helper-dependent adenoviral vector yield supraphysiological levels of alpha1-antitrypsin with negligible toxicity","volume":"9","author":"Morral","year":"1998","journal-title":"Hum. Gene Therapy"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0800","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/ng0892-372","article-title":"Adenovirus-mediated in vivo gene transfer and expression in normal rat liver","volume":"1","author":"Jaffe","year":"1992","journal-title":"Nat. Genet."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0805","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1073\/pnas.89.1.89","article-title":"Expression of human alpha 1-antitrypsin in dogs after autologous transplantation of retroviral transduced hepatocytes","volume":"89","author":"Kay","year":"1992","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0810","first-page":"815","article-title":"Therapeutic serum concentrations of human alpha-1-antitrypsin after adenoviral-mediated gene transfer into mouse hepatocytes","volume":"21","author":"Kay","year":"1995","journal-title":"Hepatology"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0815","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1126\/science.2017680","article-title":"Adenovirus-mediated transfer of a recombinant alpha 1-antitrypsin gene to the lung epithelium in vivo","volume":"252","author":"Rosenfeld","year":"1991","journal-title":"Science"},{"key":"10.1016\/j.mrrev.2017.03.001_bib0820","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1002\/jgm.896","article-title":"Therapeutic level of functional human alpha 1 antitrypsin (hAAT) secreted from murine muscle transduced by adeno-associated virus (rAAV1) vector","volume":"8","author":"Lu","year":"2006","journal-title":"J. Gene Med."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0825","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/sj.gt.3301422","article-title":"Stable therapeutic serum levels of human alpha-1 antitrypsin (AAT) after portal vein injection of recombinant adeno-associated virus (rAAV) vectors","volume":"8","author":"Song","year":"2001","journal-title":"Gene Ther."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0830","doi-asserted-by":"crossref","first-page":"14384","DOI":"10.1073\/pnas.95.24.14384","article-title":"Sustained secretion of human alpha-1-antitrypsin from murine muscle transduced with adeno-associated virus vectors","volume":"95","author":"Song","year":"1998","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0835","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1006\/bbrc.1994.2565","article-title":"Expression of human alpha 1-antitrypsin in mouse after in vivo gene transfer to hepatocytes by small liposomes","volume":"204","author":"Alino","year":"1994","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0840","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1165\/ajrcmb.10.1.8292378","article-title":"Aerosol and intravenous transfection of human alpha 1-antitrypsin gene to lungs of rabbits","volume":"10","author":"Canonico","year":"1994","journal-title":"Am. J. Respir. Cell Mol. Biol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0845","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1089\/hum.2015.044","article-title":"Challenges and prospects for alpha-1 antitrypsin deficiency gene therapy","volume":"26","author":"Wozniak","year":"2015","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0850","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1089\/hum.2011.053","article-title":"Phase 2 clinical trial of a recombinant adeno-associated viral vector expressing alpha1-antitrypsin: interim results","volume":"22","author":"Flotte","year":"2011","journal-title":"Hum. Gene Ther."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0855","doi-asserted-by":"crossref","first-page":"5310","DOI":"10.1172\/JCI70314","article-title":"Human Treg responses allow sustained recombinant adeno-associated virus-mediated transgene expression","volume":"123","author":"Mueller","year":"2013","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0860","doi-asserted-by":"crossref","first-page":"6818","DOI":"10.3748\/wjg.v12.i42.6818","article-title":"Promoted differentiation of cynomolgus monkey ES cells into hepatocyte-like cells by co-culture with mouse fetal liver-derived cells","volume":"12","author":"Saito","year":"2006","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0865","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/jcb.20970","article-title":"In vitro differentiation of hepatic progenitor cells from mouse embryonic stem cells induced by sodium butyrate","volume":"100","author":"Zhou","year":"2007","journal-title":"J. Cell. Biochem."},{"key":"10.1016\/j.mrrev.2017.03.001_bib0870","doi-asserted-by":"crossref","first-page":"4449","DOI":"10.1073\/pnas.0700052104","article-title":"A pure population of lung alveolar epithelial type II cells derived from human embryonic stem cells","volume":"104","author":"Wang","year":"2007","journal-title":"Proc. Natl. Acad. Sci. U. S. A."}],"container-title":["Mutation Research\/Reviews in Mutation Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574216300771?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1383574216300771?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T10:22:45Z","timestamp":1761301365000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1383574216300771"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,7]]},"references-count":174,"alternative-id":["S1383574216300771"],"URL":"https:\/\/doi.org\/10.1016\/j.mrrev.2017.03.001","relation":{},"ISSN":["1383-5742"],"issn-type":[{"value":"1383-5742","type":"print"}],"subject":[],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alpha-1-antitrypsin deficiency: Genetic variations, clinical manifestations and therapeutic interventions","name":"articletitle","label":"Article Title"},{"value":"Mutation Research\/Reviews in Mutation Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mrrev.2017.03.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}